Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
06978 IMMUNOTECH-B
RT Nominal unchange0.395 0.000 (0.000%)
Latest  |  Final  |  Interim
Non-current Assets
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others358,976-11.800%407,002451,603500,759527,251
Land & other Lease Assets0--0000
Intangible Assets12,267-31.465%17,89919,55141,88242,486
Interests in Asso. & JCEs0--0000
Other Non-current Assets8,46531.342%6,4455,39489,749191,586

379,708-11.971%431,346476,548632,390761,323
Current Assets
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Inventories40--0000
Trade Receivables0--0000
Cash & Bank Balances61,74713.385%54,45846,95752,16158,448
Other Current Assets38,341-67.267%117,13440,537161,73359,666
Assets Held for Sale0--0000

100,128-41.648%171,59287,494213,894118,114
Current Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Trade Payables33,950-3.620%35,22533,60946,76037,394
S-T Debt & Leases29,279-91.922%362,469295,542351,51826,056
Other Current Liabilities385,188313.469%93,160101,055131,997145,024
Liab asso w/ Assets Held for Sale0--0000

448,417-8.646%490,854430,206530,275208,474
Net Current Assets(348,289)9.092%(319,262)(342,712)(316,381)(90,360)
Total Assets Less Current Liabilities31,419-71.968%112,084133,836316,009670,963
Non-current Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
L-T Debt & Leases71,448-8.157%77,79489,017105,655123,750
Other Non-current Liabilities47,049-8.636%51,49661,27239,46440,844

118,497-8.348%129,290150,289145,119164,594
Capital and Reserves
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
  Share Capital4,3060.000%4,3063,5763,5763,576
  Reserves(88,100)383.190%(18,233)(16,872)170,040504,859
  Others0--0000
Shareholders' Funds(83,794)501.666%(13,927)(13,296)173,616508,435
Non-controlling Interests(3,284)0.152%(3,279)(3,157)(2,726)(2,066)
Others0--0000

(87,078)406.091%(17,206)(16,453)170,890506,369
Commitments and Contingent Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Commitments----28,66635,642573,993591,276
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 04/09/2026 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB -69,867
%Change-45.883%
EPS / (LPS)RMB -0.110
NBV Per Share (¥)RMB -0.136
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.